ThinkEquity Upgrades ViroPharma (VPHM) to Buy
ThinkEquity upgrades ViroPharma (Nasdaq: VPHM) from Source of Funds to Buy.
To see more analyst ratings on VPHM Click Here.
ViroPharma Incorporated, a biopharmaceutical company, engages in the development and commercialization of products that address serious diseases with a focus on products used by physician specialists or in hospital settings in the United States and internationally.
Related Categories
UpgradesStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
